Mergers & Acquisitions: A Strategy for Focused Growth in the Biopharmaceutical Industry During Uncertain Times - Video

from Accenture Management Consulting Podcast Series · host Tom Herd and Arda Ural

With an uncertain industry outlook and some cash-rich companies, it seems likely that M&A activity will increase in the biopharmaceutical industry. In this podcast, Accenture’s Tom Herd and Arda Ural argue that a disciplined approach to M&A is vital to build shareholder value.

Episode metadata supplied by the publisher feed · Published Apr 12, 2011

Embed this episode

Attribution link and audio player

Ready to play

Mergers & Acquisitions: A Strategy for Focused Growth in the Biopharmaceutical Industry During Uncertain Times - Video

0:00 8:08

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Accenture Management Consulting Podcast Series?

This episode is 8 minutes long.

When was this Accenture Management Consulting Podcast Series episode published?

This episode was published on April 12, 2011.

Can I download this Accenture Management Consulting Podcast Series episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!